For the Inventor, By the Inventor

Enter assignee name

Lianyungang, China

Jiangsu Kanion Pharmaceutical Co., Ltd.

USPTO Granted Patents = 16

EPO Patents = 9

Trademarks = 4

Forward Citations = 14

Loading Chart...

Loading Chart...

58 inventors (with patents filed for the assignee):

Wei Xiao (15 out of 17 patents)

Zhenzhong Wang (7 out of 16 patents)

Hanfei Hu (3 out of 3 patents)

4. Chenfeng Zhang (3 out of 3 patents)

5. Haiying He (2 out of 53 patents)

6. Bailing Yang (2 out of 5 patents)

7. Wang Shen (2 out of 44 patents)

8. Enli Zhou (2 out of 2 patents)

9. Xiujuan Chang (2 out of 2 patents)

10. Xiaodong Kang (2 out of 2 patents)

11. Yongxiang Wang (2 out of 2 patents)

12. Yun Wu (2 out of 2 patents)

13. Peng Li (2 out of 7 patents)

14. Shuhui Chen (2 out of 12 patents)

15. Jian Li (1 out of 199 patents)

16 patents: Sort by Forward Citations

1. 12409192 - Traditional Chinese medicine composition and use thereof (2025-09-09),

2. 12365686 - Compound as porcupine inhibitor and use thereof (2025-07-22),

3. 11958860 - Crystal form of compound, and preparation method therefor and use thereof (2024-04-16),

4. 11814352 - Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof (2023-11-14),

5. 11576942 - Traditional Chinese medicine composition and preparation method and application thereof (2023-02-14),

6. 11564904 - Gingko diterpene lactone composition (2023-01-31),

7. 11524041 - Ginkgo diterpene lactone composition (2022-12-13),

8. 11254635 - Emodin succinyl ester compound, preparation method therefor and application thereof (2022-02-22),

9. 10227339 - Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate (2019-03-12),

10. 9988361 - Anti-enterovirus 71 thiadiazolidine derivative (2018-06-05),

11. 8119141 - Cinnamomi and poria composition, method to prepare same and uses thereof (2012-02-21),

12. 7691387 - [object Object] (2010-04-06),

13. 7311930 - Herbal composition for treatment of chronic renal failure and method to produce thereof (2007-12-25),

14. 7052700 - Cinnamomi and poria composition, method to prepare same and uses thereof (2006-05-30),

15. 6919094 - Composition of medicine for treating headache disease and process of preparation and uses thereof (2005-07-19),

JIANGSU KANION PHARMACEUTICAL CO., LTD. is a leading pharmaceutical company specializing in the research, development, production, and distribution of innovative medicines. With a strong commitment to improving global health, Kanion focuses on the fields of cardiology, respiratory, endocrinology, and neurology. Their team of highly skilled professionals and advanced manufacturing facilities ensure the delivery of high-quality pharmaceutical products to patients worldwide. Visit their website for more information about their products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

16 Patents

#2 in Lianyungang

#1,603 in China

#36,654 in the World

Lianyungang, China

Jiangsu Kanion Pharmaceutical Co., Ltd.

Forward Citations = 14

58 inventors:

Wei Xiao (15 out of 17 patents)

Zhenzhong Wang (7 out of 16 patents)

Hanfei Hu (3 out of 3 patents)

4. Chenfeng Zhang (3 out of 3 patents)

5. Haiying He (2 out of 53 patents)

Please report any incorrect information to support@idiyas.com

Loading…